New registry study monitors heart and skin risks of muscle drug in toddlers
NCT ID NCT07154654
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study follows up to 10 children from birth to under 6 years old who have genetic muscle stiffness disorders (myotonic disorders) and are taking mexiletine. Researchers will track side effects like heart rhythm problems and severe skin reactions over time. The goal is to understand how safe the medicine is and how well young children can take it, such as by sprinkling capsule contents in food.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOTONIC DISORDERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.